Dr. Sock Hoai Chan and his international team have cracked a mystery that haunted five children across four unrelated families: a genetic disorder causing severe lung disease that had no name, no clear cause, and no path to treatment. Now, a landmark study published in the American Journal of Human Genetics reveals that mutations in the TMEM63B gene—specifically two broken copies inherited one from each parent—trigger a novel form of childhood interstitial lung disease marked by early respiratory distress and developmental delay.
The discovery matters because childhood lung diseases remain notoriously difficult to diagnose. Surfactant, the critical material that allows lungs to expand with each breath, depends on dozens of genes working in perfect harmony. When one fails silently, families often spend years searching for answers while their children struggle to breathe. This breakthrough gives clinicians and genetic laboratories concrete evidence to test for a previously unknown cause of surfactant dysfunction disorder.
The journey to this discovery began at Baylor College of Medicine and Texas Children's Hospital in Houston, where researchers enrolled the first patient through the Undiagnosed Diseases Network. When Dr. Keren Machol and her colleagues posted the patient's case and genetic findings online, four additional individuals from three other families came forward with strikingly similar symptoms—all carrying loss-of-function TMEM63B variants. International collaboration proved decisive; Dr. Sock Hoai Chan at KK Women's and Children's Hospital and Duke-NUS Medical School in Singapore coordinated the matching, with researchers in Asia and Europe contributing additional insights.
What makes TMEM63B particularly fascinating is how context determines devastation. The gene encodes an ion channel embedded in cells lining the brain and lungs. When patients inherit a single faulty copy that stays perpetually "on," their brains bear the brunt—causing developmental delays and epilepsy. But when children inherit two broken copies, the channel vanishes entirely. The brain compensates, finding alternative ion channels to do the work. The lung cannot. "The brain has other channels that can pick up the slack. But in the lung, there is no ability to make up for the loss of that channel," explained Dr. Jill Rosenfeld, associate professor of molecular and human genetics at Baylor.
This biological insight transformed five isolated cases into a coherent diagnosis. The patients' symptoms—early onset respiratory distress, lung abnormalities, and developmental delay without epilepsy—precisely mirrored laboratory mice engineered to lack the Tmem63b gene entirely. Functional testing confirmed the loss-of-function mechanism in all five patients, cementing the link between TMEM63B variants and this previously uncharacterized condition.
For affected families, the implications reach far beyond a label. Early diagnosis of surfactant-related lung disorders can be life-threatening if missed, requiring urgent, specialized management. Identifying TMEM63B variants as a novel cause means pediatric pulmonologists, genetic counselors, and diagnostic laboratories worldwide now have a searchable genetic target when facing similar presentations.
Dr. Chan's closing words capture the real victory: "Through patient matching initiatives and international collaboration, we have successfully identified a novel TMEM63B-associated condition responsible for severe childhood lung disease." That global partnership—spanning Houston, Singapore, Europe, and beyond—accelerated answers for the rarest genetic conditions, proving that even orphan diseases need not remain orphaned.